Fabris, Enrico http://orcid.org/0000-0001-9458-0736
Selvarajah, Abi
Tavenier, Annerieke
Hermanides, Rik
Kedhi, Elvin
Sinagra, Gianfranco
van’t Hof, Arnoud
Article History
Accepted: 24 February 2022
First Online: 22 March 2022
Declarations
:
: No external funding was used in the preparation of this article.
: Dr. E. Kedhi reports personal fees from Abbott and personal fees from Medtronic, outside this submitted work; Dr. A. van't Hof reports grants from Medtronic, Abbott, Boehringer Ingelheim, and AstraZeneca, all outside this submitted work; Dr. E. Fabris, A. Selvarajah, A. Tavenier, R. Hermanides, and G. Sinagra have declared no potential conflicts of interest that might be relevant to this work.
: All authors have contributed significantly to the paper, in particular: EF, AvH: conception and design of paper; EF: drafting of the manuscript; AS, AT, RH, EK, GS, and AvH: revising critically the manuscript for important intellectual content.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.